Benzinga - by Avi Kapoor, Benzinga Staff Writer.
U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Wednesday.
Shares of Box, Inc. (NYSE: BOX) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter EPS and announced a $100 million expansion of its stock repurchase program.
Total revenues were up 2% on a year-over-year basis. Billings were up 6% in the fourth quarter, coming in at $379.3 million. The company also issued first-quarter revenue guidance above estimates.
Box shares climbed 7.3% to $29.25 on Wednesday.
Here are some other big stocks recording gains in today’s session.
- TRxADE HEALTH, Inc. (NASDAQ: MEDS) shares jumped 39.2% to $11.19 after the company announced a special cash dividend of $8 per share.
- American Public Education, Inc. (NASDAQ: APEI) rose 31.8% to $14.99 following upbeat quarterly results.
- Dada Nexus Limited (NASDAQ: DADA) jumped 30.6% to $2.5740. Dada Nexus said certain revenues and associated costs were overstated in past financial statements.
- Wave Life Sciences Ltd. (NYSE: WVE) rose 28.5% to $6.16 following upbeat quarterly results.
- CareMax, Inc. (NASDAQ: CMAX) jumped 23.8% to $14.72.
- Lantern Pharma Inc. (NASDAQ: LTRN) climbed 22.6% to $5.90.
- Cerus Corporation (NASDAQ: CERS) gained 22.4% to $2.4350 after the company reported better-than-expected fourth-quarter GAAP EPS results.
- Crexendo, Inc. (NASDAQ: CXDO) rose 20% to $6.43 following upbeat quarterly results.
- Allient Inc. (NASDAQ: ALNT) gained 17.4% to $35.23 after the company reported better-than-expected fourth-quarter financial results.
- CrowdStrike Holdings, Inc. (NASDAQ: CRWD) shares climbed 17.2% to $348.73 after the company reported better-than-expected fourth-quarter earnings and revenues and issued upbeat guidance for FY25.
- Fulcrum Therapeutics, Inc. (NASDAQ: FULC) gained 17.2% to $12.85.
- JD.com, Inc. (NASDAQ: JD) climbed 17% to $25.08 after the company reported fourth-quarter results above estimates, a new buyback approval and annual cash dividend.
- Lexeo Therapeutics, Inc. (NASDAQ: LXEO) rose 14.8% to $15.00.
- Hippo Holdings Inc. (NASDAQ: HIPO) gained 14.6% to $16.58 after the company reported better-than-expected fourth-quarter financial results.
- Root, Inc. (NASDAQ: ROOT) climbed 13.7% to $44.46.
- HashiCorp, Inc. (NASDAQ: HCP) gained 11.1% to $26.64 following fourth-quarter financial results.
- Sibanye Stillwater Limited (NYSE: SBSW) climbed 10.6% to $4.3450.
- Mobileye Global Inc. (NASDAQ: MBLY) gained 10.6% to $27.59.
- Super Group (SGHC) Limited (NYSE: SGHC) rose 10.1% to $3.4350 following fourth-quarter results.
- Infinera Corporation (NASDAQ: INFN) gained 10% to $5.66. Infinera announced availability of next generation multi-haul optical line system functionality for industry-leading GX series platform.
- Palantir Technologies Inc. (NYSE: PLTR) climbed 10% to $26.19 after the company announced an Army contract. The company also announced customers will showcase their work in Palantir's AI platform at the AIPCon event on Mar. 7.
- CleanSpark, Inc. (NASDAQ: CLSK) rose 10% to $16.86.
- MicroStrategy Incorporated (NASDAQ: MSTR) rose 10% to $1,156.87. MicroStrategy shares fell over 21% on Tuesday after the company announced a proposed private offering of $600 million of convertible senior notes.
- Lyft, Inc. (NASDAQ: LYFT) climbed 9.4% to $18.45.
- Couchbase, Inc. (NASDAQ: BASE) shares gained 9.2% to $29.37 after the company reported upbeat fourth-quarter sales and issued upbeat revenue guidance for the first quarter.
- Insperity, Inc. (NYSE: NSP) rose 8.4% to $103.06.
- Hewlett Packard Enterprise Company (NYSE: HPE) gained 7.9% to $19.53.
- AeroVironment, Inc. (NASDAQ: AVAV) rose 7.7% to $179.96.
- Bilibili Inc. (NASDAQ: BILI) gained 7.4% to $10.91.
- NIO Inc. (NYSE: NIO) rose 5.9% to $5.80. On Tuesday, NIO reported fourth-quarter revenue of 17.10 billion yuan ($2.41 billion), up by 6.5% year-over-year and down by 10.3% from the previous quarter.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.